Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 5611 AL 5625

Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease

Counts SE, He B, Prout JG, Michalski B, Farotti L, Fahnestock M, Mufson EJ.

Curr Alzheimer Res. 2016;13(7):800-8. doi: 10.2174/1567205013666160129095649.

Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer's Disease and Mild Cognitive Impairment

González-Domínguez R, Rupérez FJ, García-Barrera T, Barbas C, Gómez-Ariza JL.

Curr Alzheimer Res. 2016;13(6):641-53. doi: 10.2174/1567205013666160129095138.

The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease

Hays CC, Zlatar ZZ, Wierenga CE.

Cell Mol Neurobiol. 2016 Mar;36(2):167-79. doi: 10.1007/s10571-015-0261-z. Epub 2016 Feb 22.

Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis

Ma J, Zhang W, Wang HF, Wang ZX, Jiang T, Tan MS, Yu JT, Tan L.

Curr Alzheimer Res. 2016;13(3):223-33. doi: 10.2174/156720501303160217111434.

What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?

Andriuta D, Moullart V, Schraen S, Devendeville A, Meyer ME, Godefroy O; Alzheimer’s Disease Neuroimaging.

J Alzheimers Dis. 2016;51(3):793-800. doi: 10.3233/JAD-150829.

Regional Hippocampal Atrophy and Higher Levels of Plasma Amyloid-Beta Are Associated With Subjective Memory Complaints in Nondemented Elderly Subjects

Cantero JL, Iglesias JE, Van Leemput K, Atienza M.

J Gerontol A Biol Sci Med Sci. 2016 Sep;71(9):1210-5. doi: 10.1093/gerona/glw022. Epub 2016 Mar 4.

Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI

Landau SM, Horng A, Fero A, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2016 Apr 12;86(15):1377-1385. doi: 10.1212/WNL.0000000000002576. Epub 2016 Mar 11.

ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials

Wang J, Logovinsky V, Hendrix SB, Stanworth SH, Perdomo C, Xu L, Dhadda S, Do I, Rabe M, Luthman J, Cummings J, Satlin A.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):993-9. doi: 10.1136/jnnp-2015-312383. Epub 2016 Mar 23.

Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study

Xu ZP, Yang SL, Zhao S, Zheng CH, Li HH, Zhang Y, Huang RX, Li MZ, Gao Y, Zhang SJ, Zhan PY, Zhang LF, Deng L, Wei S, Liu YC, Ye JW, Ren HJ, Li N, Kong CX, Wang X, Fang L, Zhou QZ, Jiang HW, Li JR, Wang Q, Ke D, Liu GP, Wang JZ.

EBioMedicine. 2016 Feb 6;5:105-13. doi: 10.1016/j.ebiom.2016.02.014. eCollection 2016 Mar.

Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277)

Qin XY, Cao C, Cawley NX, Liu TT, Yuan J, Loh YP, Cheng Y.

Mol Psychiatry. 2017 Feb;22(2):312-320. doi: 10.1038/mp.2016.62. Epub 2016 Apr 26.

Genome research in pre-dementia stages of Alzheimer's disease

Moreno-Grau S, Ruiz A.

Expert Rev Mol Med. 2016 May 30;18:e11. doi: 10.1017/erm.2016.12.

Alterations in Glucose Metabolism in Alzheimer's Disease

Calsolaro V, Edison P.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):31-39. doi: 10.2174/1872214810666160615102809.

Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife

Racine AM, Koscik RL, Berman SE, Nicholas CR, Clark LR, Okonkwo OC, Rowley HA, Asthana S, Bendlin BB, Blennow K, Zetterberg H, Gleason CE, Carlsson CM, Johnson SC.

Brain. 2016 Aug;139(Pt 8):2261-74. doi: 10.1093/brain/aww142. Epub 2016 Jun 20.

Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers

Durazzo TC, Korecka M, Trojanowski JQ, Weiner MW, O' Hara R, Ashford JW, Shaw LM; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2016 Jul 25;54(1):99-107. doi: 10.3233/JAD-160413.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias